RESUMEN
Orf is a zoonotic parapoxvirus typically transmitted to humans by a bite from goats or sheep. We present an unusual case of multiple orf lesions on the fingers of a 13-month-old child who was bitten by a goat and subsequently developed progressive swelling, blistering, and necrotic papulonodules of the hand followed by an additional diffuse, pruritic, papular rash. A primary diagnosis of orf infection was confirmed using real-time polymerase chain reaction, and the diffuse eruption was clinically consistent with an id reaction. Extensive necrosis and papular id reaction associated with orf rarely have been described.
Asunto(s)
Dermatitis/virología , Ectima Contagioso/diagnóstico , Animales , Mordeduras y Picaduras , Dermatitis/tratamiento farmacológico , Difenhidramina/uso terapéutico , Ectima Contagioso/tratamiento farmacológico , Exantema/etiología , Glucocorticoides/administración & dosificación , Cabras , Antagonistas de los Receptores Histamínicos H1/uso terapéutico , Humanos , Lactante , Masculino , Virus del Orf , Reacción en Cadena en Tiempo Real de la Polimerasa , Piel/patología , Piel/virología , Triamcinolona/administración & dosificaciónRESUMEN
Although it has been >30 years since the eradication of smallpox, the unearthing of well-preserved tissue material in which the virus may reside has called into question the viability of variola virus decades or centuries after its original occurrence. Experimental data to address the long-term stability and viability of the virus are limited. There are several instances of well-preserved corpses and tissues that have been examined for poxvirus viability and viral DNA. These historical specimens cause concern for potential exposures, and each situation should be approached cautiously and independently with the available information. Nevertheless, these specimens provide information on the history of a major disease and vaccination against it.
Asunto(s)
ADN Viral/aislamiento & purificación , Viabilidad Microbiana , Viruela/prevención & control , Viruela/virología , Virus de la Viruela/fisiología , Autopsia , Cadáver , Historia del Siglo XVIII , Historia del Siglo XIX , Historia del Siglo XX , Historia Antigua , Humanos , Viruela/historia , Viruela/transmisión , Vacuna contra Viruela/inmunología , Manejo de Especímenes/métodos , Vacunación , Virus Vaccinia/inmunología , Virus de la Viruela/aislamiento & purificación , Virus de la Viruela/patogenicidadRESUMEN
A wildlife hospital and rehabilitation center in northwestern United States received several big brown bats with necrosuppurative osteomyelitis in multiple joints. Wing and joint tissues were positive by PCR for poxvirus. Thin-section electron microscopy showed poxvirus particles within A-type inclusions. Phylogenetic comparison supports establishment of a new genus of Poxviridae.
Asunto(s)
Quirópteros/virología , Poxviridae/clasificación , Animales , Genoma Viral , Masculino , Datos de Secuencia Molecular , Filogenia , Poxviridae/genética , Poxviridae/aislamiento & purificación , Poxviridae/ultraestructuraRESUMEN
Identification of human monkeypox cases during 2005 in southern Sudan (now South Sudan) raised several questions about the natural history of monkeypox virus (MPXV) in Africa. The outbreak area, characterized by seasonally dry riverine grasslands, is not identified as environmentally suitable for MPXV transmission. We examined possible origins of this outbreak by performing phylogenetic analysis of genome sequences of MPXV isolates from the outbreak in Sudan and from differing localities. We also compared the environmental suitability of study localities for monkeypox transmission. Phylogenetically, the viruses isolated from Sudan outbreak specimens belong to a clade identified in the Congo Basin. This finding, added to the political instability of the area during the time of the outbreak, supports the hypothesis of importation by infected animals or humans entering Sudan from the Congo Basin, and person-to-person transmission of virus, rather than transmission of indigenous virus from infected animals to humans.
Asunto(s)
Brotes de Enfermedades , Mpox/virología , Animales , Genes Virales , Humanos , Tipificación Molecular , Mpox/epidemiología , Mpox/transmisión , Monkeypox virus/clasificación , Monkeypox virus/genética , Monkeypox virus/aislamiento & purificación , Filogenia , Filogeografía , Análisis de Secuencia de ADN , Sudán/epidemiologíaRESUMEN
To determine the outbreak source of monkeypox virus (MPXV) infections in Unity State, Sudan, in November 2005, we conducted a retrospective investigation. MPXV was identified in a sub-Sahelian savannah environment. Three case notification categories were used: suspected, probable, and confirmed. Molecular, virologic, and serologic assays were used to test blood specimens, vesicular swabs, and crust specimens obtained from symptomatic and recovering persons. Ten laboratory-confirmed cases and 9 probable cases of MPXV were reported during September-December 2005; no deaths occurred. Human-to-human transmission up to 5 generations was described. Our investigation could not fully determine the source of the outbreak. Preliminary data indicate that the MPXV strain isolated during this outbreak was a novel virus belonging to the Congo Basin clade. Our results indicate that MPXV should be considered endemic to the wetland areas of Unity State. This finding will enhance understanding of the ecologic niche for this virus.
Asunto(s)
Brotes de Enfermedades , Monkeypox virus/clasificación , Mpox/epidemiología , Adolescente , Adulto , Animales , Anticuerpos Antivirales/sangre , Niño , Preescolar , Congo , Femenino , Humanos , Inmunoglobulina G/sangre , Inmunoglobulina M/sangre , Lactante , Masculino , Mpox/inmunología , Mpox/transmisión , Mpox/virología , Monkeypox virus/genética , Monkeypox virus/inmunología , Monkeypox virus/aislamiento & purificación , Reacción en Cadena de la Polimerasa/métodos , Sudán/epidemiología , Adulto JovenRESUMEN
Vaccination has transformed public health, most notably including the eradication of smallpox. Despite its profound historical importance, little is known of the origins and diversity of the viruses used in smallpox vaccination. Prior to the twentieth century, the method, source and origin of smallpox vaccinations remained unstandardised and opaque. We reconstruct and analyse viral vaccine genomes associated with smallpox vaccination from historical artefacts. Significantly, we recover viral molecules through non-destructive sampling of historical materials lacking signs of biological residues. We use the authenticated ancient genomes to reveal the evolutionary relationships of smallpox vaccination viruses within the poxviruses as a whole.
Asunto(s)
Genoma Viral , Vacuna contra Viruela/historia , Virus Vaccinia/genética , Guerra Civil Norteamericana , Variación Genética , Historia del Siglo XIX , Humanos , Metagenoma , Vacunación/instrumentaciónRESUMEN
Recent enhanced monkeypox (MPX) surveillance in the Democratic Republic of Congo, where MPX is endemic, has uncovered multiple cases of MPX and varicella zoster virus (VZV) coinfections. The purpose of this study was to verify if coinfections occur and to characterize the clinical nature of these cases. Clinical, epidemiological, and laboratory results were used to investigate MPX/VZV coinfections. A coinfection was defined as a patient with at least one Orthopoxvirus/MPX-positive sample and at least one VZV-positive sample within the same disease event. Between September 2009 and April 2014, 134 of the 1,107 (12.1%) suspected MPX cases were confirmed as MPX/VZV coinfections. Coinfections were more likely to report symptoms than VZV-alone cases and less likely than MPX-alone cases. Significantly higher lesion counts were observed for coinfection cases than for VZV-alone but less than MPX-alone cases. Discernible differences in symptom and rash severity were detected for coinfection cases compared with those with MPX or VZV alone. Findings indicate infection with both MPX and VZV could modulate infection severity. Collection of multiple lesion samples allows for the opportunity to detect coinfections. As this program continues, it will be important to continue these procedures to assess variations in the proportion of coinfected cases over time.
Asunto(s)
Coinfección/epidemiología , Coinfección/virología , Herpes Zóster/epidemiología , Herpesvirus Humano 3/genética , Monkeypox virus/genética , Mpox/epidemiología , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Niño , Preescolar , República Democrática del Congo/epidemiología , Monitoreo Epidemiológico , Femenino , Herpesvirus Humano 3/aislamiento & purificación , Humanos , Lactante , Masculino , Persona de Mediana Edad , Monkeypox virus/aislamiento & purificación , Adulto JovenRESUMEN
Possible smallpox reemergence drives research for third-generation vaccines that effectively neutralize variola virus. A comparison of neutralization assays using different substrates, variola and vaccinia (Dryvax and modified vaccinia Ankara [MVA]), showed significantly different 90% neutralization titers; Dryvax underestimated while MVA overestimated variola neutralization. Third-generation vaccines may rely upon neutralization as a correlate of protection.
Asunto(s)
Anticuerpos Neutralizantes/sangre , Anticuerpos Antivirales/sangre , Pruebas de Neutralización/métodos , Vacuna contra Viruela/inmunología , Virus Vaccinia/inmunología , Virus de la Viruela/inmunología , HumanosRESUMEN
Volepox virus (VPXV) was first isolated in 1985 from a hind foot scab of an otherwise healthy California vole (Microtus californicus). Subsequent surveys in San Mateo County, CA, revealed serological evidence suggesting that VPXV is endemic to this area, and a second viral isolate from a Pinyon mouse (Peromyscus truei) was collected in 1988. Since then, few studies have been conducted regarding the ecology, pathology, and pathogenicity of VPXV, and its prevalence and role as a potential zoonotic agent remain unknown. To increase our understanding of VPXV disease progression, we challenged 24 California mice (Peromyscus californicus) intranasally with 1.6 × 10(3) PFU of purified VPXV. By day five post infection (pi) we observed decreased activity level, conjunctivitis, ruffled hair, skin lesions, facial edema, and crusty noses. A mortality rate of 54% was noted by day eight pi. In addition, internal organ necrosis and hemorrhages were observed during necropsy of deceased or euthanized animals. Viral loads in tissues (brain, gonad, kidney, liver, lung, spleen, submandibular lymph node, and adrenal gland), bodily secretions (saliva, and tears), and excretions (urine, and/or feces) were evaluated and compared using real time-PCR and tissue culture. Viral loads measured as high as 2 × 10(9) PFU/mL in some organs. Our results suggest that VPXV can cause extreme morbidity and mortality within rodent populations sympatric with the known VPXV reservoirs.
Asunto(s)
Orthopoxvirus/patogenicidad , Animales , ADN Viral/análisis , ADN Viral/genética , Femenino , Pruebas Hematológicas , Inmunidad Humoral , Masculino , América del Norte , Peromyscus/virología , Infecciones por Poxviridae/sangre , Infecciones por Poxviridae/epidemiología , Infecciones por Poxviridae/inmunología , Infecciones por Poxviridae/veterinariaRESUMEN
The search for a 'third'-generation smallpox vaccine has resulted in the development and characterization of several vaccine candidates. A significant barrier to acceptance is the absence of challenge models showing induction of correlates of protective immunity against variola virus. In this light, virus neutralization provides one of few experimental methods to show specific 'in vitro' activity of vaccines against variola virus. Here, we provide characterization of the ability of a modified vaccinia virus Ankara vaccine to induce variola virus-neutralizing antibodies, and we provide comparison with the neutralization elicited by standard Dryvax vaccination.
Asunto(s)
Anticuerpos Antivirales/sangre , Vacuna contra Viruela/inmunología , Virus de la Viruela/inmunología , Animales , Humanos , Pruebas de Neutralización/métodosRESUMEN
For the 2003 monkeypox virus (MPXV) outbreak in the United States, interhuman transmission was not documented and all case-patients were near or handled MPXV-infected prairie dogs. We initiated a case-control study to evaluate risk factors for animal-to-human MPXV transmission. Participants completed a questionnaire requesting exposure, clinical, and demographic information. Serum samples were obtained for analysis of immunoglobulin G (IgG) and IgM to orthopoxvirus. When data were adjusted for smallpox vaccination, case-patients were more likely than controls to have had daily exposure to a sick animal (odds ratio [OR] 4.0, 95% confidence interval [CI] 1.2-13.4), cleaned cages and bedding of a sick animal (OR 5.3, 95% CI 1.4-20.7), or touched a sick animal (OR 4.0, 95% CI 1.2-13.4). These findings demonstrate that human MPXV infection is associated with handling of MPXV-infected animals and suggest that exposure to excretions and secretions of infected animals can result in infection.
Asunto(s)
Mpox/epidemiología , Adolescente , Adulto , Animales , Estudios de Casos y Controles , Humanos , Oportunidad Relativa , Factores de Riesgo , Sciuridae/virología , Estados Unidos/epidemiologíaRESUMEN
BACKGROUND: In April 2003, an outbreak of monkeypox occurred in the United States following the importation of monkeypox virus (MPXV)-infected animals in a consignment of exotic pets from West Africa. Transmission of the virus to non-African captive species, including prairie dogs, preceded human disease. METHODS: We evaluated the influence of the route of infection on clinical illness for persons with confirmed and probable cases of human monkeypox. Exposures were categorized as being "noninvasive" (e.g., the person touched an infected animal, cleaned an infected animal's cage, and/or stood within 6 feet of an infected animal) or "complex" (e.g., invasive bite or scratch from an ill prairie dog plus potential noninvasive exposure), and associations between exposure, illness manifestation, and illness progression (i.e., elapsed time from first exposure to an ill prairie dog through various benchmarks of illness) were assessed. RESULTS: Patients with complex exposures were more likely than patients with noninvasive exposures to have experienced pronounced signs of systemic illness (49.1% vs. 16.7%; P=.041) and to have been hospitalized during illness (68.8% vs. 10.3%; P<.001). Complex exposures were also associated with shorter incubation periods (9 days for complex exposures vs. 13 days for noninvasive exposures) and the absence of a distinct febrile prodrome. CONCLUSIONS: The findings of this study indicate that route of infection can influence monkeypox illness manifestations.